Literature DB >> 10932076

Chemokine stromal cell-derived factor 1alpha activates basophils by means of CXCR4.

T Jinquan1, H H Jacobi, C Jing, C M Reimert, S Quan, S Dissing, L K Poulsen, P S Skov.   

Abstract

BACKGROUND: The CXC chemokine receptor 4 (CXCR4) is predominantly expressed on inactivated naive T lymphocytes, B lymphocytes, dendritic cells, and endothelial cells. CXC chemokine stromal cell-derived factor 1alpha (SDF-1alpha) is the only known ligand for CXCR4. To date, the CXCR4 expression and function of SDF-1alpha in basophils are unknown.
OBJECTIVE: The purpose of this study was to investigate the expression of CXCR4 and functions of SDF-1alpha in basophils and to characterize the role of the CXCR4-SDF-1alpha receptor ligand pair in the allergic inflammation.
METHODS: Basophil purification, flow cytometry, real-time quantitative RT-PCR assay, Northern blotting, intracellular free Ca(2+) change, chemotaxis assay, and histamine release assay were used.
RESULTS: CXCR4 is abundantly expressed on peripheral blood resting basophils (91%). Likewise, CXCR4 messenger (m)RNA is expressed in resting basophils (3.2 x 10(3) copies per 2 x 10(2) cells). The existence of CXCR4 mRNA was also confirmed in basophils by means of Northern blot analysis. SDF-1alpha induces an increase in intracellular free Ca(2+) in basophils. SDF-1alpha activates basophils to chemotaxis (chemotactic index = 3.8) and histamine release (36% of total content) through CXCR4 on the cells. The chemokines SDF-1alpha, eotaxin, RANTES, monocyte chemoattractant protein (MCP) 1, and macrophage inflammatory protein (MIP) 1alpha have been demonstrated at different potencies in induction of chemotaxis (eotaxin > SDF-1alpha > RANTES congruent with MCP-1 >> MIP-1alpha) and histamine release (MCP-1 congruent with SDF-1alpha > eotaxin > RANTES > MIP-1alpha). The optimal concentration seen for SDF-1alpha effects (chemotaxis and histamine release) on basophils was 100 ng/mL.
CONCLUSION: These results indicate that the CXCR4-SDF-1alpha receptor ligand pair may be important for the recruitment and activation of the basophils, which is a characteristic effector cell of the allergic inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10932076     DOI: 10.1067/mai.2000.108108

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  9 in total

1.  Suppression of CXCR4 expression in mast cells upon IgE-mediated antigen stimulation.

Authors:  Junji Matsuura; Mariko Sakanaka; Norio Sato; Atsushi Ichikawa; Satoshi Tanaka
Journal:  Inflamm Res       Date:  2009-08-21       Impact factor: 4.575

2.  AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity.

Authors:  Nicholas W Lukacs; Aaron Berlin; Dominique Schols; Renato T Skerlj; Gary J Bridger
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

3.  Positive regulation of CXCR4 expression and signaling by interleukin-7 in CD4+ mature thymocytes correlates with their capacity to favor human immunodeficiency X4 virus replication.

Authors:  Nathalie Schmitt; Laurent Chêne; David Boutolleau; Marie-Thérèse Nugeyre; Eric Guillemard; Pierre Versmisse; Catherine Jacquemot; Françoise Barré-Sinoussi; Nicole Israël
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

4.  The Anti-inflammatory Effect of the CXCR4 Antagonist-N15P Peptide and Its Modulation on Inflammation-Associated Mediators in LPS-Induced PBMC.

Authors:  Xue-mei Mo; Han-xiao Sun
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

Review 5.  Innate immune cells in liver inflammation.

Authors:  Evaggelia Liaskou; Daisy V Wilson; Ye H Oo
Journal:  Mediators Inflamm       Date:  2012-08-09       Impact factor: 4.711

6.  Prostaglandin D2 amplifies lupus disease through basophil accumulation in lymphoid organs.

Authors:  Christophe Pellefigues; Barbara Dema; Yasmine Lamri; Fanny Saidoune; Nathalie Chavarot; Charlotte Lohéac; Emeline Pacreau; Michael Dussiot; Caroline Bidault; Florian Marquet; Mathieu Jablonski; Jonathan M Chemouny; Fanny Jouan; Antoine Dossier; Marie-Paule Chauveheid; Delphine Gobert; Thomas Papo; Hajime Karasuyama; Karim Sacré; Eric Daugas; Nicolas Charles
Journal:  Nat Commun       Date:  2018-02-20       Impact factor: 14.919

7.  Increased Frequency of CTLA-4 and PD-1 Expressing Regulatory T Cells and Basophils With an Activating Profile in Infants With Moderate-to-Severe Atopic Dermatitis Hypersensitized to Food Allergens.

Authors:  Agurtzane Bilbao; Raquel Pérez-Garay; Idoia Rius; Alex Irurzun; Iñigo Terrén; Ane Orrantia; Gabirel Astarloa-Pando; Francisco Borrego; Olatz Zenarruzabeitia
Journal:  Front Pediatr       Date:  2021-11-29       Impact factor: 3.418

8.  Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease.

Authors:  Francesca Pizzolo; Annalisa Castagna; Oliviero Olivieri; Domenico Girelli; Simonetta Friso; Filippo Stefanoni; Silvia Udali; Veronica Munerotto; Marcello Baroni; Vera Cetera; Giovanni Battista Luciani; Giuseppe Faggian; Francesco Bernardi; Nicola Martinelli
Journal:  J Am Heart Assoc       Date:  2021-02-24       Impact factor: 5.501

Review 9.  Is There a Role for Basophils in Cancer?

Authors:  Giancarlo Marone; John T Schroeder; Fabrizio Mattei; Stefania Loffredo; Adriana Rosa Gambardella; Remo Poto; Amato de Paulis; Giovanna Schiavoni; Gilda Varricchi
Journal:  Front Immunol       Date:  2020-09-08       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.